All In Biotech

Free tool

FAERS Monitor: Abilify Maintena Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202971 or its brand name (Abilify Maintena Kit, Aripiprazole). Reports on generic versions are filed under their own applications.

Reports

50,729

Serious

40,598

80% of reports

Hospitalization

18,991

Death reported

3,761

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,990
  • off label use3,660
  • product use in unapproved indication3,098
  • weight increased2,709
  • drug interaction2,504
  • anxiety2,166
  • condition aggravated1,873
  • fatigue1,818
  • suicide attempt1,716
  • suicidal ideation1,660
  • psychotic disorder1,642
  • nausea1,627
  • somnolence1,592
  • schizophrenia1,588
  • akathisia1,496

Reports by year received

View as table
YearReports
200468
2005111
2006161
2007217
2008192
2009256
2010342
2011354
2012534
2013487
2014945
20152,167
20162,091
20173,545
20183,905
20193,887
20203,923
20215,155
20224,387
20234,862
20244,971
20254,466
20263,703

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,430 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
schizophreniaSignal1,58862.259.083,096
akathisiaSignal1,49650.948.365,198
psychotic disorderSignal1,64224.423.234,759
suicide attemptSignal1,71612.011.516,928
suicidal ideationSignal1,6607.67.39,439
drug interactionSignal2,5046.66.411,874
product use in unapproved indicationSignal3,0985.25.110,604
weight increasedSignal2,7095.14.98,820
somnolenceSignal1,5923.33.12,549
anxietySignal2,1663.23.03,239
condition aggravatedSignal1,8732.62.51,800
off label use3,6601.71.71,186
drug ineffective4,9901.61.51,103
fatigue1,8181.00.92
nausea1,6270.90.843

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.